Article
Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo.
Proceedings of the National Academy of Sciences of the United States of America - 2 Feb 2016
Hayashi Masahiro, Jin Ying, Yorgov Daniel, Santorico Stephanie A, Hagman James, Ferrara Tracey M, Jones Kenneth L, Cavalli Giulio, Dinarello Charles A, Spritz Richard A
Abstract excerpt
HLA-A is a class I major histocompatibility complex receptor that presents peptide antigens on the surface of most cells. Vitiligo, an autoimmune disease in which skin melanocytes are destroyed by cognate T cells, is associated with variation in the HLA-A gene; specifically HLA-A*02:01, which presents multiple vitiligo melanocyte autoantigens. Refined genetic mapping localizes vitiligo risk in the HLA-A region to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
